PARIS — France will allow international travelers who have had AstraZeneca’s Indian-manufactured vaccine into the country starting Sunday.
At the same time, France is tightening border checks to control the spread of the delta variant and protect hospitals, according to a statement from the prime minister Saturday.
The move to accept visitors vaccinated with AstraZeneca’s vaccine made by India’s Serum Institute came after global outcry over the fact that the European Union’s COVID-19 certificate only recognizes AstraZeneca vaccines manufactured in Europe. Several other EU countries already accept the Indian version. France still does not recognize vaccinations by Chinese or Russian vaccines, only those authorized by the EU medicines regulator.
Tunisia, Indonesia, Cuba and Mozambique have now been added to France’s “red list” of countries with high virus risk, according to Saturday’s statement.
GENEVA (AP) — The World Health Organization said Friday that COVID-19 no longer qualifies as a global emergency, marking a symbolic end to the devastating coronavirus pandemic that triggered once-unthinkable lockdowns, upended economies and killed millions of people worldwide.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.07 USD
